Mixed
GLP-1 receptor agonists used for weight management are associated with nutritional deficiencies, specifically protein deficiency and metabolic acidosis, which may lead to malnutrition.
When using GLP-1 medications for weight loss, pay attention to your nutrition. Reports suggest a higher risk of protein deficiency and metabolic acidosis. Ensure you are eating enough protein and staying hydrated. If you feel unwell, dizzy, or experience unusual symptoms, talk to your doctor about your diet and medication.
In particular, we identified that metabolic acidosis and protein deficiency were AEs enriched in GLP- 1RA usage in weight control/obesity, consistent with several case reports summarized by Fallows [15].
Why this rating
Based on FAERS disproportionality analysis, which signals potential risks but requires clinical correlation.
Source
Evaluating the Evolving Real‐World Adverse Events of <scp>GLP</scp> ‐ <scp>1RAs</scp> Using <scp>FDA</scp> Adverse Event Reporting System ( <scp>FAERS</scp> )
David Stone et al. · Obesity · 2026
DOI 10.1002/oby.70176
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →